Get the Stockscreener App
2.80
2.19%
0.06
After Hours:
2.86
0.06
+2.14%
Accendra Health Inc stock is traded at $2.80, with a volume of 1.27M.
It is up +2.19% in the last 24 hours and up +0.00% over the past month.
Owens & Minor Inc distributes consumable medical supplies to a variety of providers. The business is under two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment manufactures and sources medical surgical products through its production and kitting operations and provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. The Patient Direct segment provides delivery of disposable medical supplies sold directly to patients and home health agencies. Majority of the revenue is generated from Products & Healthcare Services segment.
See More
Previous Close:
$2.74
Open:
$2.74
24h Volume:
1.27M
Relative Volume:
0.67
Market Cap:
$216.57M
Revenue:
$10.42B
Net Income/Loss:
$-38.77M
P/E Ratio:
-5.4902
EPS:
-0.51
Net Cash Flow:
$323.54M
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
-46.97%
1Y Performance:
-69.80%
1-Day Range:
$2.69
$2.82
1-Week Range:
$2.69
$2.82
52-Week Range:
$2.38
$9.55
Accendra Health Inc Stock (OMI) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 723-7000
Address
10900 NUCKOLS ROAD, GLEN ALLEN, VA
Compare OMI vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMI
Accendra Health Inc
|
2.80 | 216.57M | 10.42B | -38.77M | 323.54M | -0.51 |
MCK
Mckesson Corporation
|
881.94 | 107.42B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
327.27 | 62.37B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
207.23 | 48.57B | 244.67B | 1.68B | 5.51B | 6.9487 |
HSIC
Henry Schein Inc
|
74.02 | 8.54B | 13.18B | 419.00M | 521.00M | 3.2704 |
AHG
Akso Health Group Adr
|
2.27 | 2.06B | 14.85M | -136.07M | 7.23M | -0.4726 |
Accendra Health Inc Stock (OMI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Jan-17-19 | Initiated | UBS | Neutral |
| Nov-01-18 | Reiterated | Barclays | Underweight |
| Oct-31-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-08-18 | Initiated | Barclays | Underweight |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Dec-19-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-01-17 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Nov-07-16 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-21-16 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-16-16 | Initiated | Credit Suisse | Underperform |
| Dec-07-15 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Accendra Health Inc Stock (OMI) Latest News
Accendra Health (ACH) CEO surrenders shares to cover RSU tax obligations - Stock Titan
Accendra Health (ACH) CFO surrenders 11,286 shares for tax withholding - Stock Titan
Accendra Health (ACH) COO surrenders shares for tax withholding, retains stake - Stock Titan
Accendra Health (ACH) EVP uses 9,347 shares to cover tax withholding - Stock Titan
Tranche Update on Accendra Health, Inc.'s Equity Buyback Plan announced on February 28, 2025. - marketscreener.com
Fitch Maintains Accendra Health's Rating Watches; Withdraws Ratings - marketscreener.com
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
Is the Options Market Signaling a Surge in Accendra Health Shares? - Bitget
OMI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Accendra Health (ACH) grants 61,437 restricted shares to EVP counsel - Stock Titan
ACH Technical Analysis & Stock Price Forecast - Intellectia AI
Owens & Minor, Inc. (OMI) Stock Analysis: Is The 94% Potential Upside Worth The Risk? - DirectorsTalk Interviews
Owens & Minor, Inc. (NYSE:OMI) Q4 2025 Earnings Call Transcript - Insider Monkey
Accendra Health, Inc. 2025 Q4ResultsEarnings Call Presentation (NYSE:ACH) 2026-02-25 - Seeking Alpha
Accendra Health (ACH) Price Target Decreased by 12.16% to 3.32 - Nasdaq
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care - Insider Monkey
UBS cuts Accendra Health stock price target on 2026 guidance By Investing.com - Investing.com Canada
UBS cuts Accendra Health stock price target on 2026 guidance - Investing.com South Africa
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Accendra Health (ACH) and Travere Therapeutics (TVTX) - The Globe and Mail
MSN Money - MSN
Tighter CMS Coverage Rules Put Accendra Health’s Non-Invasive Ventilation Revenue and Liquidity at Risk - TipRanks
Accendra Health: Debt Reduction Creates Long-Term Opportunity (Upgrade) (NYSE:ACH) - Seeking Alpha
Accendra Health (ACH) Faces Lowered Price Target by Leerink Part - GuruFocus
Accendra Health bets on Optum contract, leaner structure - HME News
Accendra Health : Reports Fourth Quarter 2025 Financial Results Prepared Remarks - marketscreener.com
Accendra Health sees 3% YOY growth, embarks on ‘next chapter’ - HME News
Accendra Health earnings missed by $0.01, revenue fell short of estimates - Investing.com Nigeria
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navi - GuruFocus
Accendra Health reports Q4 adjusted EPS 21c, consensus 22c - TipRanks
Accendra Health Posts 2025 Results, Guides 2026 Outlook - TipRanks
Accendra Health Reports Fourth Quarter 2025 Financial Results - marketscreener.com
Earnings Scheduled For February 19, 2026 - Benzinga
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call - Business Wire
Accendra Health Stock Surges on Key Executive Appointment - AD HOC NEWS
Owens & Minor Appoints Dirk Benson as Chief Commercial Officer, Effective February 4, 2026 - marketscreener.com
Accendra Health Begins Trading Under 'ACH' Ticker After Owens & Minor Divestment - marketscreener.com
Owens & Minor, Inc. (OMI) Stock Analysis: Exploring a 94% Potential Upside in Healthcare Distribution - DirectorsTalk Interviews
Owens & Minor changes name to Accendra Health - MSN
Owens & Minor, Inc. (OMI): Investor Outlook Reveals 94% Potential Upside Amidst Challenging Valuation - DirectorsTalk Interviews
AASTOCKS Financial NewsAccendra Health, Inc. (ACH) - AASTOCKS.com
Owens & Minor rebrands as Accendra Health in transformation - MSN
Accendra Health (ACH) Price Target Decreased by 69.55% to 3.77 - Nasdaq
Accendra Health (ACH): Citigroup Lowers Price Target, Maintains Buy Rating | ACH Stock News - GuruFocus
Implied Volatility Surging for Accendra Health Stock Options - sharewise.com
Accendra Health Inc Stock (OMI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.47%
4.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):